PSYMED VENTURES MANAGEMENT LLC

Thesis

PsyMed Ventures is a venture capital firm established in 2020 and headquartered in San Francisco, California, dedicated to investing in the future of brain and mental health. The firm focuses on innovative neuroscience and frontier technologies, with a mission to transform the mental and brain illness epidemic into a flourishing future by supporting groundbreaking advancements. Their investment thesis targets companies at the forefront of mental and brain health, with a strong emphasis on psychedelic medicine, neurotechnology, precision psychiatry, digital therapeutics, and AI-driven approaches. They are particularly interested in companies that bridge pharmacological and device-based approaches. The firm invests in Pre-Seed, Seed, Seed Plus, Series A, and Series A Plus stages, with a global geographic scope but a primary orientation towards the United States. They manage a $25 million fund, announced in 2022, and typically invest between $500,000 and $1,500,000 per deal, aiming to fund between 20 and 25 startups. Founders can submit proposals through the firm's website at psymed.ventures.

Related lists

• Pre-seed AI investors
• Seed-stage AI investors
• Series A AI investors